Introduction: Increased use of nanomaterials has raised concerns about the potential for undesirable human health and environmental effects. Releases into the air may occur and, therefore, the inhalation route is of specific interest. Here we tested copper oxide nanoparticles (CuO NPs) after repeated inhalation as hazard data for this material and exposure route is currently lacking for risk assessment. Methods: Rats were exposed nose-only to a single exposure concentration and by varying the exposure time, different dose levels were obtained (C × T protocol). The dose is expressed as 6 h-concentration equivalents of 0, 0.6, 2.4, 3.3, 6.3, and 13.2 mg/m3 CuO NPs, with a primary particle size of 10 9.2–14 nm and an MMAD of 1.5 μm. Results: Twenty-four hours after a 5-d exposure, dose-dependent lung inflammation and cytotoxicity were observed. Histopathological examinations indicated alveolitis, bronchiolitis, vacuolation of the respiratory epithelium, and emphysema in the lung starting at 2.4 mg/m3. After a recovery period of 22 d, limited inflammation was still observed, but only at the highest dose of 13.2 mg/m3. The olfactory epithelium in the nose degenerated 24 h after exposure to 6.3 and 13.2 mg/m3, but this was restored after 22 d. No histopathological changes were detected in the brain, olfactory bulb, spleen, kidney and liver. Conclusion: A 5-d, 6-h/day exposure equivalent to an aerosol of agglomerated CuO NPs resulted in a dose-dependent toxicity in rats, which almost completely resolved during a 3-week post-exposure period.

Introduction: Increased use of nanomaterials has raised concerns about the potential for undesirable human health and environmental effects. Releases into the air may occur and, therefore, the inhalation route is of specific interest. Here we tested copper oxide nanoparticles (CuO NPs) after repeated inhalation as hazard data for this material and exposure route is currently lacking for risk assessment.Methods: Rats were exposed nose-only to a single exposure concentration and by varying the exposure time, different dose levels were obtained (CxT protocol). The dose is expressed as 6h-concentration equivalents of 0, 0.6, 2.4, 3.3, 6.3, and 13.2mg/m(3) CuO NPs, with a primary particle size of 10 9.2-14nm and an MMAD of 1.5m.Results: Twenty-four hours after a 5-d exposure, dose-dependent lung inflammation and cytotoxicity were observed. Histopathological examinations indicated alveolitis, bronchiolitis, vacuolation of the respiratory epithelium, and emphysema in the lung starting at 2.4mg/m(3). After a recovery period of 22 d, limited inflammation was still observed, but only at the highest dose of 13.2mg/m(3). The olfactory epithelium in the nose degenerated 24h after exposure to 6.3 and 13.2mg/m(3), but this was restored after 22 d. No histopathological changes were detected in the brain, olfactory bulb, spleen, kidney and liver.Conclusion: A 5-d, 6-h/day exposure equivalent to an aerosol of agglomerated CuO NPs resulted in a dose-dependent toxicity in rats, which almost completely resolved during a 3-week post-exposure period.

Organ burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposure

MANODORI, Laura;BRUNELLI, ANDREA;HRISTOZOV, DANAIL RUMENOV;
2016-01-01

Abstract

Introduction: Increased use of nanomaterials has raised concerns about the potential for undesirable human health and environmental effects. Releases into the air may occur and, therefore, the inhalation route is of specific interest. Here we tested copper oxide nanoparticles (CuO NPs) after repeated inhalation as hazard data for this material and exposure route is currently lacking for risk assessment.Methods: Rats were exposed nose-only to a single exposure concentration and by varying the exposure time, different dose levels were obtained (CxT protocol). The dose is expressed as 6h-concentration equivalents of 0, 0.6, 2.4, 3.3, 6.3, and 13.2mg/m(3) CuO NPs, with a primary particle size of 10 9.2-14nm and an MMAD of 1.5m.Results: Twenty-four hours after a 5-d exposure, dose-dependent lung inflammation and cytotoxicity were observed. Histopathological examinations indicated alveolitis, bronchiolitis, vacuolation of the respiratory epithelium, and emphysema in the lung starting at 2.4mg/m(3). After a recovery period of 22 d, limited inflammation was still observed, but only at the highest dose of 13.2mg/m(3). The olfactory epithelium in the nose degenerated 24h after exposure to 6.3 and 13.2mg/m(3), but this was restored after 22 d. No histopathological changes were detected in the brain, olfactory bulb, spleen, kidney and liver.Conclusion: A 5-d, 6-h/day exposure equivalent to an aerosol of agglomerated CuO NPs resulted in a dose-dependent toxicity in rats, which almost completely resolved during a 3-week post-exposure period.
2016
10
File in questo prodotto:
File Dimensione Formato  
Gosens et al., 2016.pdf

non disponibili

Tipologia: Versione dell'editore
Licenza: Accesso chiuso-personale
Dimensione 1.02 MB
Formato Adobe PDF
1.02 MB Adobe PDF   Visualizza/Apri

I documenti in ARCA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10278/3678014
Citazioni
  • ???jsp.display-item.citation.pmc??? 35
  • Scopus 108
  • ???jsp.display-item.citation.isi??? 102
social impact